Abiraterone Availability in 2026: What's Really Going On?

If you're a prostate cancer patient taking Abiraterone Acetate (brand names Zytiga and Yonsa), you may have heard concerns about drug shortages — or experienced trouble finding the medication yourself. In this article, we'll give you a clear, up-to-date picture of Abiraterone availability in 2026 and what you can do to make sure you don't miss a dose.

Is Abiraterone Still in Shortage?

As of early 2026, Abiraterone is not listed on the FDA Drug Shortage database. This is good news — it means there isn't an official, widespread supply disruption.

However, that doesn't mean every pharmacy has it on the shelf. Abiraterone is a specialty oncology medication, and many retail pharmacies simply don't stock it. This can create the feeling of a shortage even when the overall supply is stable.

The key difference: a true drug shortage means manufacturers can't make enough to meet demand. With Abiraterone, the issue is more often about distribution and access — getting the drug from manufacturers to the specific pharmacy where you need it.

Why Is Abiraterone Hard to Find?

Even without a formal shortage, several factors can make Abiraterone difficult to fill:

Specialty Distribution

Abiraterone is primarily dispensed through specialty pharmacies rather than regular retail pharmacies. If your prescription was sent to a standard pharmacy that doesn't stock it, they'll need to special-order it — which takes time.

Insurance Barriers

Many insurance plans require prior authorization for Abiraterone, and some require step therapy (trying other treatments first). These requirements can delay access by days or weeks. Even once approved, specialty tier copays can be a barrier.

Multiple Generic Manufacturers

On the positive side, multiple companies now manufacture generic Abiraterone, including Apotex, Amneal, Teva, and CivicaScript. This competition has helped stabilize supply and driven prices down significantly from the original brand-name cost.

For more detail on access challenges, read why Abiraterone is so hard to find.

What Does Abiraterone Cost in 2026?

The cost picture for Abiraterone has improved dramatically thanks to generic competition:

• Brand-name Zytiga: $8,000–$12,000 per month
• Generic Abiraterone (retail without coupons): $275–$6,000 per month depending on strength and pharmacy
• Generic Abiraterone with coupons: As low as $90–$151 per month through GoodRx or SingleCare
• CivicaScript (nonprofit generic): $120–$171 per month for 120 tablets of 250 mg

Copay assistance programs can reduce costs even further:

• Apotex Instant Savings Card: Pay as little as $5 per 30-day supply (up to $6,000/year savings)
• Amneal Copay Card: Pay as little as $10 per month (up to $1,200/year savings)

For a complete guide to reducing your costs, see how to save money on Abiraterone.

New Options for Patients in 2026

Several developments have improved access to Abiraterone and prostate cancer treatment in general:

CivicaScript Generic Launch

CivicaScript, a nonprofit pharmaceutical company, launched a generic Abiraterone product at a significantly reduced price. Their mission is to make essential medications affordable and accessible. Their generic Abiraterone 250 mg is available for around $120 per bottle of 120 tablets — one of the most affordable options on the market.

Yonsa (Fine-Particle Formulation)

Yonsa offers a fine-particle formulation of Abiraterone that can be taken at a lower dose (500 mg instead of 1,000 mg) and can be taken with or without food. This added flexibility can be helpful for patients who struggle with the empty-stomach requirement of standard Abiraterone.

Akeega (Combination Therapy)

Akeega combines Abiraterone Acetate with Niraparib (a PARP inhibitor) in a single pill. It's approved for patients with specific genetic mutations (BRCA) in their prostate cancer. While it's not a direct replacement, it represents a new option in the treatment landscape.

How to Find Abiraterone in Stock Right Now

If you need Abiraterone today, here's what to do:

1. Search on Medfinder — find pharmacies near you with Abiraterone in stock
2. Contact your oncologist's office — they can direct you to specialty pharmacies they work with
3. Try independent pharmacies — they may be more flexible about ordering specialty drugs
4. Ask about home delivery — many specialty pharmacies ship directly to you

For a step-by-step guide, read how to find Abiraterone in stock near you.

What to Do If You Miss Doses

If supply issues are causing you to miss doses of Abiraterone, contact your oncologist immediately. Missing doses of cancer medication can affect your treatment outcomes. Your doctor may be able to:

• Connect you with a different pharmacy that has stock
• Provide bridge samples to tide you over
• Adjust your treatment plan temporarily if needed
• Recommend an alternative medication if the access issue is ongoing

Final Thoughts

While Abiraterone is not in an official shortage in 2026, finding it can still be challenging due to its specialty status. The good news is that generic competition has driven prices down significantly, copay assistance programs are available, and tools like Medfinder make it easier than ever to locate pharmacies with stock.

Stay proactive about your refills, work closely with your oncology team, and don't wait until you're out of medication to start looking. Your cancer treatment is too important to leave to chance.